A growth-hormone-releasing peptide studied for belly fat
From $252/mo with a 3-month plan A licensed provider reviews your intake and decides whether it's appropriate for you. Your provider picks your starting dose and adjusts it as you go.
Made by a licensed compounding pharmacy. Compounded medications are not FDA-approved.
Research on this treatment is early, mostly from animal or small human studies.
Tesamorelin is FDA-approved (as Egrifta) to reduce abdominal fat in a specific HIV-related condition. It's used off-label for visceral fat; ours is compounded, alone or with ipamorelin.
Signals the pituitary to release growth hormone, which in trials reduced deep abdominal fat.
A licensed provider reviews your intake and decides whether it's appropriate for you.
Made by a licensed compounding pharmacy. Compounded medications are not FDA-approved.
Research on this treatment is early, mostly from animal or small human studies.
This isn't a full list. Your provider reviews your history and medications before prescribing.
No, compounded tesamorelin is not FDA-approved.